Delays in the diagnosis of lung cancer

por Ellis, Peter M, Vandermeer, Rachel
Publicado 2011

An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC)

por Quinton, Cindy, Ellis, Peter M.
Publicado 2011

Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System

por Dawe, David E., Ellis, Peter M.
Publicado en J Pers Med (2012)

Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?

por Al Farsi, Abdulaziz, Ellis, Peter M.
Publicado en J Thorac Dis (2015)

Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse

por Ellis, Peter M., Swaminath, Anand, Pond, Gregory R.
Publicado en Curr Oncol (2021)

Attitudes to randomized clinical trials amongst out‐patients attending a medical oncology clinic

por Ellis, Peter M., Dowsett, Sharon M., Butow, Phyllis N., Tattersall, Martin H.N.
Publicado en Health Expect (2001)

Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients

por O’Brien, Mary Ann, Ellis, Peter M., Whelan, Timothy J., Charles, Cathy, Gafni, Amiram, Lovrics, Peter, Mukherjee, Som D., Hodgson, Nicole
Publicado en Health Expect (2011)

Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

por Barron, Carly C., Tyagi, Nidhi Kumar, Alhussein, Muhammad Mustafa, Mukherjee, Som D., Ellis, Peter M., Dhesy‐Thind, Sukhbinder, Leong, Darryl P.
Publicado en Oncologist (2019)

A mixed methods approach to understand variation in lung cancer practice and the role of guidelines

por Brouwers, Melissa C, Makarski, Julie, Garcia, Kimberly, Akram, Saira, Darling, Gail E, Ellis, Peter M, Evans, William K, Giacomini, Mita, Martelli-Reid, Lorraine, Ung, Yee C
Publicado 2014

Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial

por Tsakiridis, Theodoros, Pond, Gregory R., Wright, Jim, Ellis, Peter M., Ahmed, Naseer, Abdulkarim, Bassam, Roa, Wilson, Robinson, Andrew, Swaminath, Anand, Okawara, Gordon, Wierzbicki, Marcin, Valdes, Mario, Levine, Mark
Publicado en JAMA Oncol (2021)

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

por Masters, Gregory A., Temin, Sarah, Azzoli, Christopher G., Giaccone, Giuseppe, Baker, Sherman, Brahmer, Julie R., Ellis, Peter M., Gajra, Ajeet, Rackear, Nancy, Schiller, Joan H., Smith, Thomas J., Strawn, John R., Trent, David, Johnson, David H.
Publicado en J Clin Oncol (2015)

Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients

por Martin, Petra, Shiau, Carolyn J, Pasic, Maria, Tsao, Ming, Kamel-Reid, Suzanne, Lin, Stephanie, Tudor, Roxana, Cheng, Susanna, Higgins, Brian, Burkes, Ronald, Ng, Matilda, Arif, Saroosh, Ellis, Peter M, Hubay, Stacy, Kuruvilla, Sara, Laurie, Scott A, Li, Jing, Hwang, David, Lau, Anthea, Shepherd, Frances A, Le, Lisa W, Leighl, Natasha B
Publicado en Br J Cancer (2016)